DalsnaFinance › IPOs › Protagonist Therapeutics, Inc

Protagonist Therapeutics, Inc IPO

Completed

Protagonist Therapeutics, Inc completed its initial public offering on NASDAQ on August 11, 2016, pricing at $12.00 a share.

Ticker	PTGX
Exchange	NASDAQ
Status	Completed
Listing date	August 11, 2016
Offering price	$12.00
Shares offered	7,500,000
Total raised	$90M

Company coverage

Protagonist Therapeutics, Inc — quote, profile and latest news →

Other recent IPOs

• Gores Holdings XI, Inc. · June 22, 2026
• SpaceX · June 12, 2026
• Avalanche Treasury Corp · June 11, 2026
• JAB Acquisition Corp I · June 9, 2026
• Snow Rothschild Acquisition Corp. · June 8, 2026
• INNIO N.V. · June 4, 2026
• DISCIPLINED GROWTH ACQUISITION Corp · May 26, 2026
• Peace Acquisition Corp. · May 21, 2026

IPO data is compiled from SEC filings. This page is general information, not investment advice.